Guardant Health grows with Shield blood CRC screening, Quest deal, 50M reach, 335% surge, and FY25 revenue $981M up 33%. Read ...

The study analyzed over 1.2 million cancer deaths from 1990 to 2023 and highlighted the progress made in reducing mortality rates for several types of cancer. Key contributors to this decline include: ...

New American Cancer Society research reveals colorectal cancer deaths rising among younger adults, while other cancer ...

A new report found that colorectal cancer causes more deaths than any other type of cancer, including breast and lung cancers. Experts explain why, and what it means for you.

Colorectal cancer screening remains a cornerstone of preventive medicine, with strategies evolving to reduce both incidence and mortality worldwide. Current screening programmes utilise a range of ...

Patients with an average risk for colorectal cancer (CRC) are candidates for noninvasive tests, such as multitarget stool DNA (mtsDNA), whereas those with a higher risk, including those with a family ...

Doctors recommend screening for this disease starting at age 45.

Colorectal cancer has since jumped up from being the fifth-leading cancer death in the early 1990s.

Stool DNA testing climbed sharply after the pandemic began while colonoscopy and fecal immunochemical test use fell, a study of nearly 25 million privately insured Blue Cross Blue Shield beneficiaries ...

The funding will be used to lead a five-year statewide effort known as Promoting Resource and Outreach to Enhance Colorectal ...

The researchers examined the five leading causes of cancer death among the under-50 age group. They found that overall, from 1990 through 2023, more than 1.2 million people died of cancer in the ...